| Net cash flow from operating activities |
|
|
|
|
|
|
| Profit/(loss) for the period |
|
|
|
4 686 |
|
–2 181 |
| Income taxes (income)/expenses |
|
28
|
|
3 263 |
|
1 111 |
| Interest income |
|
|
|
–29 |
|
–0 |
| Interest expenses |
|
9
|
|
2 449 |
|
2 747 |
| Dividend income from non-current assets |
|
9
|
|
– |
|
–119 |
| Profit/(loss) for the period before interest and tax |
|
|
|
10 369 |
|
1 558 |
| Depreciation, amortization and impairment |
|
8
|
|
4 329 |
|
3 882 |
| (Profit)/loss on sale of non-current assets |
|
|
|
–202 |
|
62 |
| Gain recognized on contribution of net assets into associate |
|
7
|
|
– |
|
–1 368 |
| Share of (profit)/loss of associates |
|
13
|
|
723 |
|
354 |
| Gain recognized on FV measurement on previously held interest in an associate |
|
|
|
–110 |
|
– |
| Disposal of financial liabilities as a result of forgiveness |
|
19
|
|
–400 |
|
– |
| Changes in provisions |
|
|
|
185 |
|
186 |
| Increase obsolence reserve on inventories |
|
15
|
|
624 |
|
900 |
| Change in fair value of biological assets |
|
11
|
|
–4 074 |
|
–927 |
| Other non-cash items |
|
|
|
13 |
|
–87 |
| Operating cash flow before working capital changes |
|
|
|
11 457 |
|
4 560 |
| Decrease/(increase) in trade and other receivables |
|
17
|
|
–1 213 |
|
–5 973 |
| Decrease/(increase) in inventories |
|
15
|
|
–3 887 |
|
–382 |
| Decrease/(increase) in prepayments and assets held for sale |
|
|
|
56 |
|
824 |
| Increase/(decrease) in trade payables and other liabilities |
|
18
|
|
1 174 |
|
7 112 |
| Income tax (paid)/received |
|
28
|
|
–1 538 |
|
–273 |
| Net cash flow operating activities |
|
|
|
6 049 |
|
5 868 |
| |
| Cash flow from investing activities |
| Proceeds from sale of intangible assets |
|
12
|
|
1 471 |
|
1 |
| Purchase of intangible assets |
|
12
|
|
–1 366 |
|
–125 |
| Proceeds from sale of property, plant and equipment |
|
10
|
|
15 |
|
33 |
| Purchase of property, plant and equipment |
|
10
|
|
–1 604 |
|
–3 994 |
| Acquisition of subsidiaries, net of cash |
|
32
|
|
–553 |
|
– |
| Issuance of financial assets to associates |
|
|
|
– |
|
–291 |
| Proceeds from disposal of other non-current assets |
|
|
|
– |
|
342 |
| Purchase of other non-current assets |
|
|
|
–311 |
|
–260 |
| Increase/(decrease) in recoverable taxes |
|
|
|
–13 |
|
– |
| Dividends from associates |
|
13
|
|
– |
|
138 |
| Dividends from non-current financial assets |
|
9
|
|
– |
|
119 |
| Interests received |
|
|
|
29 |
|
0 |
| Net cash flow investing activities |
|
|
|
–2 332 |
|
–4 038 |
| |
| Cash flow from financing activities |
| Proceeds from borrowings |
|
19
|
|
904 |
|
2 141 |
| Repayment of borrowings |
|
19
|
|
–3 535 |
|
–1 270 |
| Interests paid |
|
19
|
|
–1 245 |
|
–1 492 |
| Interests paid on lease liabilities |
|
19 / 21
|
|
–142 |
|
–127 |
| Repayment of lease liabilities |
|
19 / 21
|
|
–273 |
|
–815 |
| Net cash flow financing activities |
|
|
|
–4 291 |
|
–1 563 |
| |
|
|
|
|
|
|
| Net increase/(decrease) in cash and cash equivalents |
|
|
|
–574 |
|
267 |
| |
|
|
|
|
|
|
| Cash and cash equivalents, at the beginning of the year |
|
|
|
2 778 |
|
2 578 |
| Increase/(decrease) in cash and cash equivalents |
|
|
|
–574 |
|
267 |
| Translation effect on cash |
|
|
|
52 |
|
–67 |
| Total Cash and cash equivalents, at the end of the year |
|
|
|
2 256 |
|
2 778 |